Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial - Ballantyne, C M; Davidson, M H; MacDougall, D E (J Am Coll Cardiol, 2013)